Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data
- 31 October 2012
- journal article
- research article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 12 (10), 757-764
- https://doi.org/10.1016/s1473-3099(12)70168-8
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experienceVaccine, 2012
- Changes in Serogroup and Genotype Prevalence Among Carried Meningococci in the United Kingdom During Vaccine ImplementationThe Journal of Infectious Diseases, 2011
- The future of immunisation policy, implementation, and financingThe Lancet, 2011
- Costs and impact of meningitis epidemics for the public health system in Burkina FasoVaccine, 2011
- Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in AfricansThe New England Journal of Medicine, 2011
- Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina FasoPLOS ONE, 2011
- Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate VaccineClinical and Vaccine Immunology, 2011
- Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd ImmunityClinical and Vaccine Immunology, 2010
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd ImmunityThe Journal of Infectious Diseases, 2008
- Clonal Waves of Neisseria Colonisation and Disease in the African Meningitis Belt: Eight- Year Longitudinal Study in Northern GhanaPLoS Medicine, 2007